Skip to content
10-Q

Quarterly Report

BIONOVATE TECHNOLOGIES CORP.

0001640334-21-001184

← back to feed
Filed
May 17, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2021 · May 14, 2021 20.6M sh
Operating Cash Flow Q3 2021 · Mar 31, 2021 $0
Operating Cash Flow Q3 2021 · Mar 31, 2020 $0
Long Term Debt Q3 2021 · Mar 31, 2021 $0
Long Term Debt Q3 2021 · Jun 30, 2020 $0
Cash And Equivalents Q3 2021 · Mar 31, 2021 $0
Cash And Equivalents Q3 2021 · Jun 30, 2020 $0
Cash And Equivalents Q3 2021 · Mar 31, 2020 $0
Cash And Equivalents Q3 2021 · Jun 30, 2019 $0
Stockholders Equity Q3 2021 · Mar 31, 2021 −$483.64K
Stockholders Equity Q3 2021 · Dec 31, 2020 −$451.97K
Stockholders Equity Q3 2021 · Sep 30, 2020 −$419.54K
Stockholders Equity Q3 2021 · Jun 30, 2020 −$396.67K
Stockholders Equity Q3 2021 · Mar 31, 2020 −$375.7K
Stockholders Equity Q3 2021 · Dec 31, 2019 −$387.82K
Stockholders Equity Q3 2021 · Sep 30, 2019 −$361.14K
Stockholders Equity Q3 2021 · Jun 30, 2019 −$332.29K
Current Liabilities Q3 2021 · Mar 31, 2021 $483.64K
Current Liabilities Q3 2021 · Jun 30, 2020 $396.67K
Total Liabilities Q3 2021 · Mar 31, 2021 $483.64K
Total Liabilities Q3 2021 · Jun 30, 2020 $396.67K
Current Assets Q3 2021 · Mar 31, 2021 $0
Current Assets Q3 2021 · Jun 30, 2020 $0
Total Assets Q3 2021 · Mar 31, 2021 $0
Total Assets Q3 2021 · Jun 30, 2020 $0
Sga Expense Q3 2021 · Mar 31, 2021 $0
Sga Expense Q3 2021 · Mar 31, 2021 $850
Sga Expense Q3 2021 · Mar 31, 2020 $0
Sga Expense Q3 2021 · Mar 31, 2020 $0
Net Income Q3 2021 · Mar 31, 2021 −$31.67K
Net Income Q3 2021 · Mar 31, 2021 −$86.97K
Net Income Q3 2021 · Dec 31, 2020 −$32.43K
Net Income Q3 2021 · Sep 30, 2020 −$22.87K
Net Income Q3 2021 · Mar 31, 2020 −$24.14K
Net Income Q3 2021 · Mar 31, 2020 −$99.08K
Net Income Q3 2021 · Dec 31, 2019 −$45.57K
Net Income Q3 2021 · Sep 30, 2019 −$29.38K
Operating Income Q3 2021 · Mar 31, 2021 −$16.69K
Operating Income Q3 2021 · Mar 31, 2021 −$41K
Operating Income Q3 2021 · Mar 31, 2020 −$2.75K
Operating Income Q3 2021 · Mar 31, 2020 −$27.11K
Revenue Q3 2021 · Mar 31, 2021 $0
Revenue Q3 2021 · Mar 31, 2021 $0
Revenue Q3 2021 · Mar 31, 2020 $0
Revenue Q3 2021 · Mar 31, 2020 $0